SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-012645
Filing Date
2024-04-08
Accepted
2024-04-08 13:56:05
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1473
  Complete submission text file 0001127602-24-012645.txt   3090
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address GE HEALTHCARE TECHNOLOGIES INC. 500 W. MONROE CHICAGO IL 60661
Business Address
Larson Betty D (Reporting) CIK: 0001617903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 24829068